Onyx Pharmaceuticals, Inc. (ONXX) Reports Stronger-Than-Expected Q4 Results

Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) reported Q4 EPS of $1.50, $0.07 better than the analyst estimate of $1.43. Revenue for the quarter came in at $237 million versus the consensus estimate of $213.24 million.

For earnings history and earnings-related data on Onyx Pharmaceuticals, Inc. (ONXX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Burry doubles down on Nebius short after stock surges 34% on earnings
• NextPlat Corp (NXPL) Reports Q2 Loss of $0.05
• Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle